Natural Product: NPC477876

Natural Product IDNPC477876
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
[(3R,4aR,6aR,6bS,8aR,9R,10R,11S,12aR,14aR,14bR)-9-acetyloxy-10-hydroxy-11-(hydroxymethyl)-11-methoxy-4,4,6a,6b,14b-pentamethyl-2,3,4a,5,6,7,8,8a,9,10,12,12a,14,14a-tetradecahydro-1H-picen-3-yl] acetate
IUPAC Name [(3R,4aR,6aR,6bS,8aR,9R,10R,11S,12aR,14aR,14bR)-9-acetyloxy-10-hydroxy-11-(hydroxymethyl)-11-methoxy-4,4,6a,6b,14b-pentamethyl-2,3,4a,5,6,7,8,8a,9,10,12,12a,14,14a-tetradecahydro-1H-picen-3-yl] acetate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 44577085
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey KWWGOEQSGCWRKO-ROVWNBQSSA-N
Standard InCHI InChI=1S/C33H52O7/c1-19(35)39-26-13-14-30(5)24(29(26,3)4)12-16-32(7)25(30)10-9-23-22-17-33(18-34,38-8)28(37)27(40-20(2)36)21(22)11-15-31(23,32)6/h9,21-22,24-28,34,37H,10-18H2,1-8H3/t21-,22-,24+,25-,26-,27-,28-,30+,31-,32-,33+/m1/s1
SMILES CC(=O)O[C@@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@H]5[C@H]4C[C@@]([C@@H]([C@@H]5OC(=O)C)O)(CO)OC)C)C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   560.37 Volume:   590.164
?
Van der Waals volume.
Dense:   0.95 LogP:   3.163
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.285
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.267
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   28.0
TPSA:   102.29
?
Topological Polar Surface Area.
H-Bond Acceptor:   7.0
H-Bond Donor:   2.0 Rings:   5.0
Heavy Atoms:   7.0

MedChem Properties

QED Drug-Likeness Score:   0.359 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.261 Fsp3:   0.879
MCE-18:   105.806
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.916 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.013
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.254 Promiscuous compounds:   0.567

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.447 MDCK Permeability:   -5.096
Pgp-inhibitor:   0.993 Pgp-substrate:   0.028
PAMPA:   0.559
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.387 30% Bioavailability (F30%):   0.82
50% Bioavailability (F50%):   0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.531
Plasma Protein Binding (PPB):   84.0% Volume Distribution (VD):   -0.276
Fu: 9.437%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.984 BCRP inhibitor:   0.343
BSEP inhibitor:   0.998

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.19 CYP2C19-substrate:   0.013
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.281
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.06 CYP3A4-substrate:   0.022
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.999
HLM stability:   0.607
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.308 Half-life (T1/2):  0.867

ADMET: Toxicity

hERG Blockers:  0.004 hERG Blockers (10um):  0.04
Human Hepatotoxicity (H-HT):  0.391 Drug-induced Liver Injury (DILI):  0.247
AMES Toxicity:  0.257 Rat Oral Acute Toxicity:  0.087
Maximum Recommended Daily Dose:  0.072 Skin Sensitization:  0.946
Carcinogencity:  0.794 Eye Corrosion:  0.016
Eye Irritation:  0.239 Respiratory Toxicity:  0.049
Drug-induced Neurotoxicity:  0.002 Ototoxicity:  0.547
Hematotoxicity:  0.541 Drug-induced Nephrotoxicity:  0.61
Genotoxicity:  0.167 RPMI-8226 Immunitoxicity:  0.021
A549 Cytotoxicity:  0.176 Hek293 Cytotoxicity:  0.15
BCF:   1.135
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.029
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.866
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.104
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8737 Saussurea muliensis Species Asteraceae Eukaryota flowers and roots Muli Autonomous County of Sichuan, China 2005-AUG PMID[18419156]
NPO8737 Saussurea muliensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8737 Saussurea muliensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20 Organism Candida albicans Candida albicans MIC > 50 ug/ml PMID[18419156]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 50 ug/ml PMID[18419156]
NPT19 Organism Escherichia coli Escherichia coli MIC > 50 ug/ml PMID[18419156]
NPT314 Organism Bacillus cereus Bacillus cereus MIC > 50 ug/ml PMID[18419156]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC477876 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7083 Intermediate Similarity NPC477875
0.5952 Remote Similarity NPC477877
0.5526 Remote Similarity NPC191965
0.527 Remote Similarity NPC290495
0.527 Remote Similarity NPC195334
0.52 Remote Similarity NPC224145
0.5195 Remote Similarity NPC162107
0.5195 Remote Similarity NPC46912
0.5195 Remote Similarity NPC127855
0.5122 Remote Similarity NPC488520

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC477876 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data